• Your FY27 tax return will look different. Here’s what changed and how to prepare

    Frazzled couple sitting out their kitchen table trying to figure out their finances or taxes.

    The tax return you lodge for the next financial year will look different to every return you have filed before it.

    Three meaningful changes took effect on 1 July 2026 and will appear in your FY27 return.

    Understanding each of them before you lodge will help you maximise your refund and avoid common mistakes.

    Change one: the 15% tax rate

    The most important change is the reduction in the marginal tax rate on income between $18,201 and $45,000.

    That rate dropped from 16% to 15% from 1 July 2026, delivering a tax cut worth up to $268 per year to every Australian taxpayer.

    For most salary and wage earners, this adjustment was already applied to your take-home pay from 1 July through your employer’s PAYG withholding calculations.

    When you lodge your FY27 return, the ATO will calculate your tax at the new 15% rate automatically.

    You do not need to do anything specific to claim this benefit.

    However, if you changed jobs during the year, started freelancing, or had irregular income, your employer may not have withheld at exactly the right rate.

    From FY27, every Australian who earns salary or wage income can claim up to $1,000 in work-related expenses without keeping a single receipt.

    Previously, the receipt-free limit was $300.

    The new $1,000 deduction applies automatically when you lodge your return.

    For a worker on a 32.5% marginal tax rate, claiming the full $1,000 deduction is worth approximately $325 in tax savings.

    The deduction cannot be combined with specific expense claims above $1,000. If your actual work-related expenses exceed $1,000 and you have receipts to prove it, you should claim the actual amount rather than the instant deduction.

    Work-related expenses include items like home office costs, professional development, tools, uniforms, and technology used for work.

    Change three: higher Medicare levy thresholds

    Medicare levy low-income thresholds increased from 1 July 2025 and apply to the FY27 return.

    The threshold for singles rose to $28,011, up from $27,222, meaning more low-income Australians will pay no Medicare levy on their FY27 return.

    The family threshold rose to $47,238 and increases by $4,338 for each dependent child or student.

    For single seniors and pensioners, the threshold rose to $44,268.

    If you earn below these thresholds, you may be entitled to a Medicare levy reduction or exemption when you lodge.

    What to do with any tax refund

    A tax refund is not a windfall. Instead, it is the return of money you overpaid during the year.

    However, how you deploy a refund still matters.

    Spending it immediately on discretionary items means the tax cut effectively disappears into everyday consumption.

    Investing it, even a modest amount, is the start of a compounding habit.

    Commonwealth Bank of Australia (ASX: CBA) is the most widely held ASX share among Australian retail investors. The company offers a fully franked dividend yield and long-term earnings track record that suits a regular, small-investment approach.

    Alternatively, for investors who want instant diversification rather than individual stock selection, the Betashares Australia 200 ETF (ASX: A200) charges just 0.04% per annum and tracks the performance of 200 of Australia’s largest companies in a single trade.

    For global technology and AI exposure, the Betashares Nasdaq 100 ETF (ASX: NDQ) gives investors access to the world’s largest non-financial technology companies. This will includes SpaceX following its Nasdaq-100 inclusion this week.

    Foolish takeaway

    Your FY27 tax return will be simpler in some ways and more lucrative in others.

    The 15% rate and the $1,000 instant deduction both reduce your tax liability automatically.

    The Medicare levy changes may eliminate the levy entirely for lower-income earners.

    Understanding the changes before you lodge means you claim what you are entitled to, rather than leaving money on the table.

    The post Your FY27 tax return will look different. Here’s what changed and how to prepare appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Commonwealth Bank Of Australia right now?

    Before you buy Commonwealth Bank Of Australia shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Commonwealth Bank Of Australia wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why I’d buy and hold ResMed and TechnologyOne shares with $5,000

    A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.

    If I had $5,000 to invest in ASX shares, I would want to own businesses that will still be important in 10 years.

    That is why I like ResMed Inc. (ASX: RMD) and TechnologyOne Ltd (ASX: TNE).

    They operate in different markets, but both solve problems that are not likely to fade. One is helping people manage sleep and breathing disorders. The other helps important organisations run essential systems more efficiently.

    I think that gives both companies a strong starting point for long-term investors.

    ResMed shares

    ResMed is an ASX healthcare share I would happily buy with part of that $5,000.

    The company is best known for sleep apnoea devices, masks, accessories, software, and connected health technology.

    This is a great place to be. Sleep and breathing disorders remain a large, underpenetrated healthcare market. Many people are still undiagnosed or undertreated, which gives ResMed a long runway if awareness and access continue improving.

    Its recent numbers also show that demand has not disappeared. In the third quarter of FY26, ResMed reported revenue growth of 11% to US$1.4 billion. It also delivered 18% growth in non-GAAP income from operations.

    I would not buy ResMed just because one quarter looked solid. I would buy it because those numbers support the broader point: the company is still growing while investing in a market with significant long-term need.

    There are risks, including competition, GLP-1 drugs, and healthcare sentiment. But I think the market may be underestimating the durability and size of the opportunity.

    TechnologyOne shares

    TechnologyOne is another ASX share I would buy for the long term.

    The company provides enterprise software to customers such as councils, government departments, universities, and large organisations. These customers need dependable systems for finance, payroll, property, student management, compliance, and reporting.

    That type of software may not sound exciting, but I think it can be extremely valuable.

    Once these systems are embedded, replacing them can be disruptive. That gives TechnologyOne a strong customer relationship if it keeps delivering.

    The shift to software-as-a-service has also strengthened the business model and supported strong annual recurring revenue growth. In the first half of FY26, TechnologyOne reported annual recurring revenue of $598 million, up 17%. SaaS and recurring revenue increased 13% to $299.2 million.

    I also like the ambition. Management says the company is on track to surpass $1 billion in annual recurring revenue by FY30 and continues to talk about doubling the business every five years.

    That is not guaranteed, but I like businesses that have clear targets, recurring revenue, and multiple ways to grow.

    TechnologyOne is also investing heavily in artificial intelligence and its SaaS+ model. If those tools help customers simplify complex operations, the company could become even harder to replace.

    Foolish takeaway

    I think ResMed and TechnologyOne are two ASX shares worth buying with $5,000.

    What I like most is that both companies are building around real customer needs. ResMed is helping address a large healthcare problem that remains underpenetrated, while TechnologyOne is becoming more deeply embedded in organisations that need reliable software to function properly.

    Neither share is risk-free. But I think both businesses have enough growth, relevance, and ambition to reward patient investors over time.

    The post Why I’d buy and hold ResMed and TechnologyOne shares with $5,000 appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How to go from zero to $50,000 with ASX shares

    A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs, and scientific symbols as she smiles.

    Building a $50,000 ASX share portfolio from scratch is a goal for many investors.

    I think it is achievable, especially when investors stop thinking about one big lump sum and start thinking about a repeatable monthly habit.

    The share market rewards consistency over time, especially when investors use diversified exchange-traded funds (ETFs), quality ASX shares, and the power of compounding.

    Here is how I think an investor could start from zero and work toward that first $50,000 milestone.

    Start with simple building blocks

    I think one of the easiest ways to begin is with diversified ASX-listed ETFs.

    An ETF such as the Vanguard Australian Shares Index ETF (ASX: VAS) can give investors exposure to a broad basket of local companies. Another option, the Vanguard MSCI Index International Shares ETF (ASX: VGS), can provide access to global shares through one investment.

    That kind of simplicity can be useful when starting from zero.

    Investors do not need to know every company perfectly on day one. They can start by owning a broad slice of the market, then learn more as the portfolio grows.

    For someone who wants exposure to the US market, the iShares S&P 500 ETF (ASX: IVV) could also be worth considering. It gives investors access to many of the largest companies in the United States.

    Add quality ASX shares over time

    ETFs can make a strong foundation, but some investors may also want to add individual ASX shares as they gain confidence.

    That could mean looking for high-quality businesses with strong brands, lasting demand, and the ability to keep growing over time.

    For example, Commonwealth Bank of Australia (ASX: CBA) has one of the strongest banking franchises in the country, Wesfarmers Ltd (ASX: WES) has a long history of managing different businesses and allocating capital carefully, and CSL Ltd (ASX: CSL) gives investors exposure to global healthcare demand.

    Those are not automatic buys at any price. Valuation is always important.

    But I think they show the type of businesses investors could consider as their knowledge improves: companies with real earnings, strong market positions, and long-term relevance.

    How to get to $50,000

    If an investor started with nothing and invested $500 a month into ASX shares, the portfolio could build faster than many people expect.

    Assuming an average return of 9% per annum, it would take around six and a half years to reach $50,000.

    I think that is a realistic example of how regular investing, time, and compounding can work together.

    Keep going when markets move around

    It is always best to remember that a 9% annual return is only an assumption. The share market will not deliver that return neatly each year. Some years will be strong. Others will be flat, frustrating, or negative.

    That is why I think the monthly habit is so important.

    Investing $500 a month removes some of the pressure of trying to pick the perfect moment. If prices fall, investors buy at lower levels. If markets rise, the portfolio keeps participating.

    The real advantage comes from staying consistent.

    Foolish takeaway

    Going from zero to $50,000 with ASX shares requires a plan that can be repeated through different market conditions.

    With $500 a month, a sensible mix of ETFs and quality ASX shares, and enough time for compounding to work, I think investors can turn a blank starting point into a meaningful portfolio.

    The post How to go from zero to $50,000 with ASX shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Commonwealth Bank Of Australia right now?

    Before you buy Commonwealth Bank Of Australia shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Commonwealth Bank Of Australia wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has positions in CSL, Commonwealth Bank Of Australia, Vanguard Australian Shares Index ETF, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Wesfarmers, and iShares S&P 500 ETF. The Motley Fool Australia has recommended CSL, Vanguard Msci Index International Shares ETF, Wesfarmers, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Cloudflare Sees Uptick in Cyber Attacks as Internet Usage Increases

  • SpringWorks (SWTX): A Rare Cancer Biotech with Potentially >50% Upside. Recommending BUY.

  • Which markets or industries do you see perform best in the next decades (geographic vs. industry focus vs. cap size)? How do you build this into a strategy and portfolio to maximize expected risk-adjusted future returns?

  • Leading brokers name 3 ASX shares to buy today